Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)

NCT02079909 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

482

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: T-817MA-H
DRUG: T-817MA-L
DRUG: Placebo

Sponsor

FUJIFILM Toyama Chemical Co., Ltd.

Collaborators

[object Object]